Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01
Topiramate Tablet
Product Images NDC 50090-4614
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-4614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02
This appears to be a graph showing the cumulative rates for time to first seizure of two groups of individuals who were on different doses of topiramate (50mg/day and 400mg/day). The x-axis displays time in days and the y-axis displays the cumulative rate of individuals who experienced a seizure.*
Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03
The text describes the change in migraine frequency during a double-blind phase study involving Topamax medication. The data shows that the average monthly migraine period rate increased by 56 during the study. The medication dosage was either 100 mg/day or 200 mg/day. The asterisks at the bottom of the text suggest that the results were statistically significant.*
Label Image (Lbl500904614)
Product: not-available. The provided text seems to include some characters that are not readable or do not make sense.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
